$60,000 of CORTEVA AGRISCIENCE lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"EPA regulatory issues pertaining to pesticides."
You can find more data on corporate lobbying on Quiver Quantitative.
CTVA Insider Trading Activity
CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- BRIAN TITUS (See Remarks) has made 0 purchases and 2 sales selling 8,311 shares for an estimated $636,199.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTVA Hedge Fund Activity
We have seen 597 institutional investors add shares of CTVA stock to their portfolio, and 608 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,456,910 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $767,956,677
- CAPITAL INTERNATIONAL INVESTORS removed 10,801,587 shares (-92.8%) from their portfolio in Q4 2025, for an estimated $724,030,376
- HARRIS ASSOCIATES L P added 10,675,052 shares (+168.1%) to their portfolio in Q4 2025, for an estimated $715,548,735
- FMR LLC added 5,962,615 shares (+25.8%) to their portfolio in Q4 2025, for an estimated $399,674,083
- JANUS HENDERSON GROUP PLC removed 3,132,619 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $209,979,451
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,100,709 shares (+6527.4%) to their portfolio in Q4 2025, for an estimated $207,840,524
- BLACKROCK, INC. added 2,901,736 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $194,503,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTVA Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/30/2025
To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.
CTVA Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 10 analysts offer price targets for $CTVA in the last 6 months, with a median target of $81.0.
Here are some recent targets:
- Joshua Spector from UBS set a target price of $88.0 on 04/09/2026
- Bill Selesky from Argus Research set a target price of $91.0 on 03/31/2026
- John Roberts from Mizuho set a target price of $82.0 on 02/17/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $77.0 on 02/05/2026
- Arun Viswanathan from RBC Capital set a target price of $89.0 on 02/05/2026
- Michael Sison from Wells Fargo set a target price of $85.0 on 02/05/2026
- Patrick Cunningham from Citigroup set a target price of $80.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
